7. Stereotaxis (STXS - Get Report) designs, manufactures and markets cardiology instrument control systems for use in an interventional medical suite for the treatment of arrhythmias and coronary artery disease.For the 2010 fourth quarter, analysts polled by Bloomberg expect the company to report a loss of 11 cents per share, compared to a loss of 14 cents reported during the year-ago period.
10 Health Care Stocks With 100% Buy Ratings
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.